Wordt geladen...
Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled Trial
Objective: Because cholinergic deficits are prominent in dementia with Lewy bodies (DLB), we investigated the effects of a cholinesterase inhibitor, donepezil, in such patients in a randomized, double-bilnd- placebo-controlled exploratory phase 2 trial. Methods: One-hundred forty patients with DLB,...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley Subscription Services, Inc., A Wiley Company
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3504981/ https://ncbi.nlm.nih.gov/pubmed/22829268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.23557 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|